| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Department of Anesthesia (H.K., K.N., H.I.), Japanese Red Cross Society, Wakayama Medical Center, and the Department of Anesthesiology (Y.K., M.D., Y.H.), Wakayama Medical University, Wakayama; and the Department of Anesthesia (T.A.), Hiroshima General Hospital, and the Department of Anesthesiology (O.Y.), Hiroshima University School of Medicine, Hiroshima, Japan.
Correspondence to Hiroyuki Kinoshita, MD, PhD, Department of Anesthesiology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan. E-mail hkinoshi{at}pd5.so-net.ne.jp
Objective The present study was designed to examine in the human omental artery whether high concentrations of D-glucose inhibit the activity of ATP-sensitive K+ channels in the vascular smooth muscle and whether this inhibitory effect is mediated by the production of superoxide.
Methods and Results Human omental arteries without endothelium were suspended for isometric force recording. Changes in membrane potentials were recorded and production of superoxide was evaluated. Glibenclamide abolished vasorelaxation and hyperpolarization in response to levcromakalim. D-glucose (10 to 20 mmol/L) but not L-glucose (20 mmol/L) reduced these vasorelaxation and hyperpolarization. Tiron and diphenyleneiodonium, but not catalase, restored vasorelaxation and hyperpolarization in response to levcromakalim in arteries treated with D-glucose. Calphostin C and Gö6976 simultaneously recovered these vasorelaxation and hyperpolarization in arteries treated with D-glucose. Phorbol 12-myristate 13 acetate (PMA) inhibited the vasorelaxation and hyperpolarization, which are recovered by calphostin C as well as Gö6976. D-glucose and PMA, but not L-glucose, significantly increased superoxide production from the arteries, whereas such increased production was reversed by Tiron.
Conclusions These results suggest that in the human visceral artery, acute hyperglycemia modulates vasodilation mediated by ATP-sensitive K+ channels via the production of superoxide possibly mediated by the activation of protein kinase C.
Our results regarding the acute effects of high glucose on the human omental artery indicate that in the human visceral artery, acute hyperglycemia modulates vasodilation mediated by ATP-sensitive K+ channels via the production of superoxide, possibly mediated by the activation of protein kinase C.
Key Words: ATP-sensitive K+ channels high glucose human artery protein kinase C superoxide
This article has been cited by other articles:
![]() |
T. Kawano, K. Tanaka, K. Mawatari, S. Oshita, A. Takahashi, and Y. Nakaya Hyperglycemia Impairs Isoflurane-Induced Adenosine Triphosphate-Sensitive Potassium Channel Activation in Vascular Smooth Muscle Cells Anesth. Analg., March 1, 2008; 106(3): 858 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Fairchild Protection of muscle membrane excitability during cycling in humans: a role for SGLT3? J Appl Physiol, January 1, 2008; 104(1): 315 - 315. [Full Text] [PDF] |
||||
![]() |
L. Xiang, J. S. Naik, S. R. Abram, and R. L. Hester Chronic hyperglycemia impairs functional vasodilation via increasing thromboxane-receptor-mediated vasoconstriction Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H231 - H236. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Rainbow, M. E. L. Hardy, N. B. Standen, and N. W. Davies Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells J. Physiol., September 15, 2006; 575(3): 833 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kinoshita, T. Azma, H. Iranami, K. Nakahata, Y. Kimoto, M. Dojo, O. Yuge, and Y. Hatano Synthetic Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Restore Impaired Vasorelaxation via ATP-Sensitive K+ Channels by High Glucose J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 312 - 318. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |